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Abstract
Background: Long-term adherence is a major issue in patients receiving home continuous positive airway pressure (CPAP)
therapy for obstructive sleep apnea-hypopnea syndrome (OSAHS). In a multicenter prospective cohort (the Institut de
Recherche en Sante ´ Respiratoire des Pays de la Loire [IRSR] sleep cohort) of consecutive OSAHS patients in whom CPAP had
been prescribed for at least 90 days, we studied the impact on long-term treatment adherence of socioeconomic factors,
patients and disease characteristics prior to CPAP initiation.
Methods and Principal Findings: Among 1,141 patients in whom CPAP had been prescribed for an average of 5046251
days (range: 91 to 1035), 674 (59%) were adherent with a mean daily use of CPAP$4 h (mean: 6.4261.35 h). Stepwise
regression analysis identified 4 independent factors of CPAP adherence including apnea-hypopnea index (AHI) (OR: 1.549,
95%CI 1.163 to 2.062 for AHI$30 vs. AHI,30; p=0.003), body mass index (BMI) (OR: 1.786, 95%CI 1.131 to 2.822 for BMI$25
and ,30 kg/m
2, p=0.01; OR: 1.768, 95%CI 1.145–2.731 for BMI$30 kg/m
2, p=0.01 vs. BMI,25 kg/m
2), employment status
(OR: 1.414, 95%CI 1.097–1.821 for retired vs. employed; p=0.007) and marital status (OR: 1.482, 95%CI 1.088–2.019 for
married or living as a couple vs. living alone; p=0.01). Age, gender, Epworth sleepiness scale, depressive syndrome,
associated cardiovascular morbidities, educational attainment and occupation category did not influence CPAP adherence.
Conclusions: Marital status and employment status are independent factors of CPAP adherence in addition to BMI and
disease severity. Patients living alone and/or working patients are at greater risk of non-adherence, whereas adherence is
higher in married and retired patients. These findings suggest that the social context of daily life should be taken into
account in risk screening for CPAP non-adherence. Future interventional studies targeting at-risk patients should be
designed to address social motivating factors and work-related barriers to CPAP adherence.
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Introduction
Obstructive sleep apnea-hypopnea syndrome (OSAHS) is a
highly prevalent disease [1] characterized by recurrent episodes of
partial or complete obstruction of the upper airways during sleep.
Nasal continuous positive airway pressure (CPAP) during sleep is
the primary treatment of OSAHS. Randomized placebo-con-
trolled trials of CPAP therapy in OSAHS have demonstrated a
significant benefit on daytime alertness, health-related quality of
life and arterial pressure [2,3,4]. Observational studies have shown
that CPAP therapy is associated with a lower risk of driving-related
accidents [5], and fatal and nonfatal cardiovascular events [6,7]. A
number of studies have examined outcomes relative to CPAP use
and have demonstrated a dose effect of CPAP therapy in
improving symptoms, daytime sleepiness and quality of life
[8,9,10]. Although there is no consistent agreement regarding
the optimal CPAP use relative to health outcomes, a daily
use$4 h is frequently cited as a threshold for adequate treatment
adherence [11,12,13,14]. A prospective cohort study of 149
patients with OSAHS demonstrated that the greatest gain in
daytime sleepiness, as assessed by the Epworth Sleepiness Scale
[15], was obtained with 4 h use/night [9]. A reduced incidence of
cardiovascular events under CPAP was also observed in patients
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poor CPAP adherence is widely recognized as a critical problem in
the treatment of OSAHS [16,17,18,19]. When adherence is
defined as greater than 4 hours of nightly use, 46 to 83% of
patients with OSAHS have been reported to be non-adherent to
treatment [18]. Various factors that are likely to influence CPAP
adherence have been evaluated [19], including age [20], disease
severity [21,22], technical aspects [23,24,25], ambulatory versus in-
hospital management [26,27], and psychological factors [28,29].
Recent studies have demonstrated the influence of socioeco-
nomic status (SES) on CPAP treatment outcome [13,30,31,32]. In
a retrospective cohort study of 266 veterans in the USA, CPAP
adherence $4 h/night during the first week of treatment was
found to be closely associated with higher neighborhood SES [13].
In a cross-sectional study of 162 patients with newly diagnosed
OSAHS in Israel, CPAP acceptance after a 2-week adaptation
period was independently associated with individual SES as
assessed by monthly income level [30]. Almost 30% of patients
identified cost as a reason for not accepting CPAP [30] suggesting
that a co-payment policy per se is a barrier to the purchase of CPAP
in patients with low SES. Disparities in CPAP treatment outcome
were also observed between OSAHS patients recruited from
hospitals serving low SES neighborhoods compared with hospitals
serving high SES populations [31,32]. Forty-two percent of
OSAHS patients recruited in a minority-serving institution largely
treating lower income, uninsured patients failed to follow-up for
CPAP treatment compared with 7% in a voluntary hospital
primarily serving a middle-class population with health-care
insurance [31]. In this multicenter prospective cohort study we
aimed to evaluate the impact on long-term treatment adherence of
socioeconomic factors, patients and disease characteristics prior to
CPAP initiation.
Methods
Ethics statement
This study was approved by the University of Angers ethics
committee and patients gave their written informed consent.
Design and study population
Since May 15, 2007, consecutive patients $18 years in whom
CPAP is prescribed for OSAHS in 7 centers from the west of
France have been recruited in a prospective cohort (the Institut de
Recherche en Sante ´ Respiratoire des Pays de la Loire [IRSR] sleep cohort).
Inclusion criteria. All consecutive patients in whom CPAP
had been prescribed for at least 90 days on April 15, 2010 were
eligible for the present study.
Exclusion criteria. Patients with mental retardation unable
to fill in the questionnaires, patients unable to give their informed
consent, patients unable to read and/or speak French, and
patients with neuromuscular diseases were excluded from this
study.
Baseline evaluation
Baseline evaluation prior to CPAP initiation included recording
of patient characteristics, associated cardiovascular morbidities
and OSAHS disease severity. Patients filled in questionnaires
evaluating subjective daytime sleepiness, depressive symptoms and
socioeconomic factors.
Patient characteristics. Patients were characterized
according to their age (,65/$65 years), gender, body mass
index (BMI) (,25/$25 and ,30/$30 kg/m
2) and smoking
habits.
Associated cardiovascular morbidities. Patients were
classified as having cardiovascular morbidity if they reported at
least one of the following cardiovascular diseases: known and
treated hypertension, ischemic heart disease, cardiac arrhythmia,
congestive heart failure and stroke.
OSAHS disease severity. Subjects were stratified by
OSAHS severity based on an apnea-hypopnea index (AHI) cut-
off of 30 (AHI,30/$30 events per hour) measured by overnight
polysomnography (PSG) or overnight respiratory recording.
Overnight PSG was performed with continuous recording of the
following channels: electroencephalogram, electrooculogram, chin
electromyogram, arterial oxygen saturation (finger oximetry), nasal-
oral airflow (pressure cannula), electrocardiogram, chest and
abdominal wall motion (piezoelectrodes), bilateral tibialis
electromyogram, and body position. Overnight respiratory
recordings were performed with continuous recording of arterial
oxygen saturation, nasal-oral airflow, chest and abdominal wall
motion, and body position. Overnight PSG was performed under
attended conditions in the laboratory, whereas respiratory
recordings were performed either under attended conditions in the
laboratory or under unattended conditions in hospital or at home.
Respiratory events were scored manually using recommended
criteria [12].
Subjective daytime sleepiness. Excessive daytime sleepiness
was defined by an Epworth Sleepiness Scale (ESS).10 [15].
Depressive symptoms. Depression was diagnosed when at
least 7 items of the 13-item version of the Pichot depression scale
[33] were positive.
Socioeconomic factors. Using specifically designed self-
administered questionnaires from the Institut National de la
Statistique et des Etudes Economique (INSEE), SES was described
by the following variables: marital status (married or living as a
couple/living alone [never married, divorced, separated,
widowed]); employment status (employed full time or part time/
retired/unemployed); educational attainment as determined by
the age at which the patient left full-time education (#18/.18
years); and the patient’s occupational category according to
the INSEE nomenclature (Farmers/Craftsman, shopkeepers,
company directors/Executives and higher intellectual professions
/Intermediate professions, technicians, foremen/Employees/
Workers) [34].
CPAP initiation and follow-up
The decision to prescribe CPAP was based on the following
criteria: apnea-hypopnea index (AHI)$30 events per hour or AHI
between 5 and 30 events per hour with daytime sleepiness and $2
OSAHS symptoms including snoring, choking or gasping during
sleep, unrefreshing sleep, daytime fatigue, impaired concentration,
and/or nocturia. In France, CPAP treatment cost which includes
delivery and follow-up by home respiratory care companies is 65%
reimbursed by French national health insurance. All patients
included in the present study had complementary private
insurance covering the remaining 35%. Therefore, long-term
CPAP therapy was provided with no additional cost to patients in
the present study. A single home respiratory care company
(ALISEO, Beaucouze ´, France) was involved in this study for
CPAP device delivery and the follow-up support program.
Following the diagnosis of OSAHS, a board-certified sleep
specialist prescribed CPAP therapy using either a fixed pressure
device or a self-adjusting pressure device. According to French
practice guidelines for OSAHS treatment [35], auto-titrating
pressure devices were preferentially used in patients with sleep-
stage and body position-dependent OSAHS and in those requiring
high levels of CPAP. All patients were treated with devices
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precise index of daily use by measuring the time spent with the
mask on. For patients treated with a fixed CPAP, the effective
pressure was determined either manually during titration PSG or
by using the 95
th percentile pressure recorded during an
unattended home automatic titration over at least one week
[27]. Before CPAP titration, all patients received treatment
education including explanation of the treatment by a specialized
nurse, mask-fitting, and a CPAP acclimatization period during the
daytime. All patients received a phone call from the specialized
nurse during the first week of treatment and follow-up visits with
the specialized nurse were then held at 3 months, 6 months and
then every 6 months. According to the French recommendations
for reimbursement of CPAP therapy, patients were reviewed in
consultation by the sleep specialist during the first 5 months, at 12
months then at least annually. Daily CPAP use was recorded at
each follow-up visit. Heated humidification was added when nasal
side effects of CPAP were reported during follow-up [36]. An oro-
nasal mask was used in patients with major mouth leaks under
CPAP [37]. Nasal pillows were used in some patients as an
alternative to nasal mask in order to provide relief to skin pressure
areas, especially the nasal bridge [38].
Primary outcome variable
The primary dependent variable of interest was CPAP
adherence as assessed by mean daily CPAP use recorded at each
follow-up visit. Patients were classified as CPAP-adherent when
they were still using CPAP with a mean daily use of at least 4 h/
night. Non-adherence corresponded to patients who refused
CPAP therapy or who had stopped treatment or who were still
using treatment but for an average of less than 4 h/night.
Statistical analysis
All statistical analyses were performed with SAS software (SAS/
STAT Package 2002–2003 by SAS Institute Inc., Cary, NC,
USA). Adherent and non-adherent patients were compared using
Chi-square test for categorical variables and 2-sample t-test for
continuous variables. A logistic procedure with backward stepwise
regression analysis was then used to determine independent
variables influencing CPAP adherence. Only variables with a P
value,0.05 were included in the model and were considered to
have a significant impact on adherence with CPAP therapy.
Results were expressed as mean 6 standard deviation (SD) and
adjusted odds ratios (95% confidence intervals).
Results
A flow diagram is presented in Figure 1. Between May 15, 2007
and April 15, 2010, CPAP was prescribed in 1,389 consecutive
patients with OSAHS. Fifty-one patients were excluded from the
IRSR sleep cohort due to at least one of the abovementioned
exclusion criteria. In 133 patients, CPAP had been prescribed for
,90 days. Therefore, 1,205 consecutive patients, in whom CPAP
had been prescribed for at least 90 days, were included in the
present study. Sixty-four patients were lost to follow-up or had no
available adherence data. Data from 1,141 patients in whom
CPAP had been prescribed for an average of 5046251 days
(range: 91 to 1035) were available for analysis. Forty-seven percent
of patients were treated with fixed CPAP and 53% were treated
with a self-adjusting pressure device at the time of last follow-up. A
humidification system was used in 48% of cases. A total of 467
(41%) patients were considered to be non-adherent, including 42
(3.7%) patients who had refused CPAP, 170 (14.9%) patients who
had abandoned treatment after a mean duration of 2176181 days
and 255 (22.3%) patients who were still using CPAP, but for less
than 4 h/night (mean: 2.3661.19 h/night). Six hundred and
seventy four (59%) patients were CPAP-adherent with a mean
daily use of the device of 6.4261.35 h.
Comparison of adherent and non-adherent patients (Table 1)
demonstrated significant differences for BMI, AHI, marital status
and employment status. Non-adherence was associated with a
higher rate of employed patients, living alone, with normal weight
and mild-to-moderate OSAHS, but a lower rate of obese and
retired patients. There was also a trend for a higher rate of current
smokers in non-adherent patients (p=0.051). No significant
difference was observed between adherent and non-adherent
patients in terms of age, gender, ESS, depressive syndrome,
associated cardiovascular morbidities, educational attainment and
occupation.
Multivariate analysis (Table 2) indicated that CPAP adherence
was associated with 4 independent variables including AHI (OR:
1.549, 95%CI 1.163 to 2.062 for AHI$30 vs. AHI,30;
p=0.003), body mass index (BMI) (OR: 1.786, 95%CI 1.131 to
2.822 for BMI$25 and ,30 kg/m
2, p=0.01; OR: 1.768, 95%CI
1.145–2.731 for BMI$30 kg/m
2, p=0.01 vs. BMI,25 kg/m
2),
employment status (OR: 1.414, 95%CI 1.097–1.821 for retired vs.
employed; p=0.007) and marital status (OR: 1.482, 95%CI
1.088–2.019 for married or living as a couple vs. living alone;
p=0.01).
Discussion
In this multicenter prospective cohort study, 59% of 1,141
OSAHS patients where CPAP-adherent with a mean daily CPAP
use $4 h an average of 504 days after the initial prescription. Our
findings support an independent influence of marital status and
employment status on long-term CPAP adherence. In line with
previous reports [20,21], we also demonstrated that BMI and
OSAHS severity are independent predictors of long-term CPAP
adherence.
Few studies have evaluated the influence of social support
(mainly by partner) on CPAP adherence. In a prospective cohort
study of 80 consecutive OSAHS patients, Lewis et al. [39] found
that those subjects who lived alone used their machines
significantly less than those who lived with a partner, suggesting
that living with another person may encourage regular CPAP use.
Simon-Tuval et al. [30] demonstrated that social support from
family and/or friends’ positive experience with CPAP was an
independent predictor to increase the odds of CPAP acceptance
(OR=2.6 and 2.9 for the whole group and patients living with a
partner, respectively). The bed partner’s post-treatment sleep
quality and overall quality of life were also demonstrated to
influence CPAP adherence [40]. In a small population of married
men, CPAP adherence was strongly related to the frequency with
which the couple slept together [41]. Recent studies have more
extensively investigated how the social context of daily life may
impact on perceptions of CPAP treatment [42,43]. Married
OSAHS patients described close sources of support (i.e., spouse,
living partner, family members) as important to provide feedback
about their response to treatment, troubleshooting difficulties and
positive reinforcement for persistent CPAP use [43]. A study of
spousal involvement in CPAP adherence among 31 OSAHS
patients found that the patient’s perception of the wife’s support
predicted increased adherence in patients with high disease
severity [42]. Increased positive wife involvement occurred as a
reaction to adherence and problems with CPAP [42]. Our findings
and those of previous research [30,39,42,43] suggest that marital
status should be taken into account in risk screening for CPAP
Socioeconomic Status and CPAP Adherence
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living partner involvement as an adherence intervention. In
unmarried OSAHS patients, family members, friends and/or
coworkers could constitute social support resources and be
involved in future educational strategies to improve CPAP
adherence.
The independent effect of employment status on treatment
adherence has been demonstrated in various disease settings. A
prospective cohort study of patients undergoing warfarin therapy
showed an increased risk of non-adherence in patients currently
employed compared to unemployed and retired patients [44].
Among patients with inflammatory bowel disease, men with lower
medication adherence were more likely to be employed on a full-
time basis [45]. Work-related barriers including being away from
home and being too busy or distracted to properly comply were
also identified in patients with HIV infection receiving highly
active antiretroviral therapy [46]. Work performances have been
demonstrated to be impaired in OSAHS patients with excessive
daytime sleepiness and to improve in response to CPAP treatment
[47]. Unfortunately, the present study demonstrates that employed
OSAHS patients are at greater risk of CPAP non-adherence
compared to retired patients. Although the underlying relationship
is not certain, active employment might reflect numerous
competing interests which take precedence over regular CPAP
use. CPAP machines are often considered to be bulky, which can
contribute to limit CPAP adherence in patients travelling for work.
Furthermore, conflicting demands imposed by work schedules
may compromise long-term CPAP follow-up visit attendance.
Further studies should be designed to better address work-related
barriers to CPAP adherence.
Two recent studies found that economic status, as assessed by
income level [30] and neighborhood of residence [13], is an
independent factor of CPAP adherence. Treatment cost was
identified as a reason for declining CPAP by 30% of patients [30]
suggesting that co-payment policy may contribute to the negative
impact of low SES on CPAP acceptance. As income levels and
neighborhood of residence were not measured in the present
study, the potential influence of these parameters on CPAP
adherence cannot be excluded. However, no link was observed
between long-term CPAP adherence and two of the variables
defining economic status, i.e. educational attainment and
occupational category. In the present study, CPAP therapy was
provided with no additional cost to patients. It can therefore be
hypothesized that the absence of a co-payment policy may have
attenuated the influence of economic factors on CPAP adherence.
In line with previous reports, we found no independent
influence of age [20,21,22] and gender [21,22] on long-term
CPAP adherence. We and other authors have found that obesity is
an independent predictive factor of better CPAP adherence [20].
In the large study from McArdle et al. [21], obesity was not an
independent predictive factor of CPAP adherence, but increasing
BMI was a significant determinant of the number of hours of use
Figure 1. Flow diagram of subjects during the study. Abbreviations: CPAP: continuous positive airway pressure; IRSR, Institut de Recherche en
Sante ´ Respiratoire des Pays de la Loire.
doi:10.1371/journal.pone.0022503.g001
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Variables Adherent patients Non-adherent patients P
N 674 467
Age $65 years (%) 23.3 21.6 0.49
Female (%) 26 29.1 0.24
Current smokers (%) 16.6 21.4 0.05
Body mass index (kg/m
2) 32.9 (6.7) 32.1 (6.9) 0.03
Body mass index,25 kg/m
2 (%) 7.4 12.9 0.01
Body mass index $25 and #30 kg/m
2 (%) 30.5 29
Body mass index .30 kg/m
2 (%) 62.1 58.1
Apnea-hypopnea index 46.4 (22.1) 41.5 (21.3) 0.0002
Apnea-hypopnea index ,30 (%) 19.7 29.3 0.0002
Epworth sleepiness scale 10.6 (4.9) 10.5 (5.2) 0.83
Epworth sleepiness scale ,11 (%) 49.6 50.3 0.85
Pichot depression score $7 (%) 20.8 24.2 0.18
Patients with cardiovascular morbidity (%) 63.5 61.5 0.27
Married or living as a couple (%) 78.8 72.8 0.03
Patients who left full-time education #18 years (%) 71.2 69.4 0.63
Employment status 0.01
Employed full time or part time (%) 40.6 46.7
Unemployed (%) 4.9 7.2
Retired (%) 54.5 46.1
Last occupation 0.75
Farmers (%) 4.1 4.1
Craftsman, shopkeepers, company directors (%) 9.1 10.9
Executives and higher intellectual professions (%) 15.3 15.9
Intermediate professions, technicians, foremen (%) 14.7 16.9
Employees (%) 14.0 14.1
Workers (%) 26.7 23.6
Missing data (%) 16.3 14.6
*Results presented as mean (standard deviation) unless otherwise indicated.
Adherent patients: continuous positive airway pressure (CPAP) use $4 h/night.
Non-adherent patients: CPAP refused or abandoned, or CPAP use,4 h/night.
Significant level for p value: ,0.05.
doi:10.1371/journal.pone.0022503.t001
Table 2. Stepwise regression analysis of variables influencing CPAP adherence.
Variables b (Standard error) Odds ratio (95%CI) P
AHI: $30 (vs. ,30) 0.437 (0.146) 1.549 (1.163–2.062) 0.003
Body mass index (vs. ,25 kg/m
2)
$25 and ,30 kg/m
2 0.580 (0.233) 1.786 (1.131–2.822) 0.01
$30 kg/m
2 0.570 (0.222) 1.768 (1.145–2.731) 0.01
Employment status (vs. employed)
Unemployed 20.341 (0.284) 0.711 (0.407–1.242) 0.23
Retired 0.346 (0.129) 1.414 (1.097–1.821) 0.007
Marital status: Married or living as a couple (vs. living alone) 0.393 (0.158) 1.482 (1.088–2.019) 0.01
Abbreviations: CPAP, continuous positive airway pressure; AHI, apnea-hypopnea index;
CPAP adherence: CPAP use $4 h/night.
Significant level for p value: ,0.05.
Area under the ROC: 0.607.
doi:10.1371/journal.pone.0022503.t002
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and CPAP adherence is unclear. Previous investigations of health
belief model in OSAHS [29] found that higher BMI prior to
CPAP treatment was associated with greater functional limitations
including lower activity levels, poorer vigilance and lower
productivity throughout the day. It can be hypothesized that
higher perceived functional limitations due to OSAHS in
overweight and obese patients contribute to increase CPAP
adherence, but this remains to be demonstrated.
Our results corroborate the findings of most previous investi-
gations demonstrating that the severity of sleep-disordered
breathing, as assessed by AHI or oxygen desaturation index, is a
determinant of long-term CPAP use [20,21,22,30]. Conversely,
daytime sleepiness prior to CPAP treatment, as assessed by ESS, is
an inconsistent predictor of adherence in the literature [29]. In
contrast to the study from McArdle et al. [21], we did not find that
non-sleepy patients with ESS,11 at diagnosis are less likely to
adhere to CPAP, although the two studies are comparable in terms
of sample size and the rate of non-sleepy patients (40–50%).
Furthermore, no link was demonstrated between depressive
symptoms and CPAP adherence in our study. Several recent
studies have also failed to demonstrate any influence of ESS and
psychological variables on CPAP adherence [13,22,29,30] sug-
gesting that the severity of daytime sleepiness does not play a
pivotal role in terms of long-term treatment adherence. Post-
treatment perception of an improvement in ESS was found to be
predictive of ongoing CPAP use, but is of limited value for the
identification of patients likely to present poor adherence prior to
initiation of therapy [19].
This study presents a number of limitations. The impact of
technical factors and initial CPAP exposure factors on treatment
adherence was not evaluated [19]. Technical aspects such as
CPAP mode, humidification or interface were likely to be modified
during treatment follow-up. These parameters are therefore of
limited value in the prediction of treatment adherence prior to
CPAP initiation. Regarding initial CPAP exposure factors, recent
prospective randomized studies failed to demonstrate any impact
of ambulatory versus in-hospital management on CPAP treatment
outcome [26,27]. Despite the prospective design of this study, the
missing data rate was about 15% for occupational categories that
might have contributed to a selection bias. However, the missing
data rate was similar in adherent and non-adherent patients.
In conclusion, marital status and employment status are
independent factors of CPAP adherence in addition to BMI and
disease severity. Patients living alone and/or working patients are
at greater risk of non-adherence, whereas adherence is higher in
married and retired patients. These findings suggest that the social
context of daily life should be taken into account in risk screening
for CPAP non-adherence. Future interventional studies targeting
at-risk patients should be designed to address social motivating
factors and work-related barriers to CPAP adherence.
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